Zoloft Lawsuit News: Bernstein Liebhard LLP Notes New Pretrial Order in Federal Zoloft Litigation Establishing Tentative Date for First Bellwether Trial

Share Article

The Firm is currently investigating Zoloft lawsuits on behalf of families whose child was born with a birth defect allegedly associated with their mother’s use of Zoloft during pregnancy.

Bernstein Liebhard LLP | Consumer Injury Lawyers
Bellwether trials will provide valuable insight into how juries might weigh claims in similar Zoloft lawsuits. We are pleased with the progress in this litigation.

Zoloft lawsuits continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. According to a Pretrial Order issued on February 25th, the Zoloft litigation’s first trial is tentatively scheduled to begin on October 13, 2014. The next Status Conference in the litigation has been scheduled for April 2, 2013 (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation - MDL 2342)

“Bellwether trials will provide valuable insight into how juries might weigh claims in similar Zoloft lawsuits. We are pleased with the progress in this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Zoloft lawsuit consultations to victims of birth defects allegedly associated with the drug.

Zoloft Birth Defect Lawsuits
Zoloft is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. In November 2006, the FDA added warnings about a potential risk of persistent pulmonary hypertension in newborns (PPHN) from Zoloft and other SSRI antidepressants when taken after the 20th week of pregnancy.* In September 2009, a study published in the British Medical Journal found that SSRI antidepressants like Zoloft increase the risk of heart defects when taken during the first trimester.**

Court documents indicate that at least 250 Zoloft lawsuits are pending in the Eastern District of Pennsylvania. All of the lawsuits allege that use of Zoloft during pregnancy can increase the risk of delivering a child with severe birth defects, including pulmonary hypertension in newborns (PPHN), spina bifida and other neural tube defects, heart defects, abdominal defects, and club foot.

Victims of possible Zoloft side effects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about alleged Zoloft birth defects, please visit Bernstein Liebhard LLP’s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today by calling (877) 779-1414.

*fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126522.htm
** bmj.com/content/339/bmj.b3569

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website